YONGAN PHARMACEUTICAL(002365)

Search documents
永安药业:公司股价严重偏离基本面
news flash· 2025-05-28 09:15
永安药业(002365)发布股票交易严重异常波动暨风险提示公告,公司股票交易价格于2025年5月15日 至2025年5月28日连续十个交易日内收盘价格涨幅偏离值累计超过100%,属于股票交易严重异常波动情 形。近期公司股价短期涨幅较大,已严重偏离公司基本面,存在较高的炒作风险。2025年一季度,公司 处于亏损状态。公司特别提醒投资者注意投资风险,理性决策,审慎投资。 ...
A股永安药业触及涨停录得11天7板,成交额12.13亿元。
news flash· 2025-05-28 02:32
A股永安药业触及涨停录得11天7板,成交额12.13亿元。 订阅A股涨停捉妖队 +订阅 ...
永安药业触及涨停录得11天7板
news flash· 2025-05-28 02:32
这几只票暗盘资金正在偷偷流入,立即查看>> 永安药业(002365)触及涨停录得11天7板,成交额12.13亿元。 ...
永安药业(002365) - 关于股票交易异常波动暨风险提示公告
2025-05-27 08:32
本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 重要风险提示: 1、潜江永安药业股份有限公司(以下简称"公司",证券简称:永安药业, 证券代码:002365)股票交易价格于 2025 年 5 月 23 日、2025 年 5 月 26 日、2025 年 5 月 27 日连续三个交易日内日收盘价格涨幅偏离值累计超出 20%,根据深圳 证券交易所的有关规定,属于股票交易异常波动的情况。公司股价短期涨幅较大, 敬请广大投资者理性投资,注意投资风险。 证券代码:002365 证券简称:永安药业 公告编号:2025-36 潜江永安药业股份有限公司 关于股票交易异常波动暨风险提示公告 针对公司股票交易异常波动,公司董事会对公司相关事项进行了核实,现 就有关情况说明如下: (一)经核查,公司前期披露的信息不存在需要更正、补充之处。 2、公司于 2025 年 5 月 6 日披露了《关于公司实际控制人、董事长被留置的 公告》(公告编号:2025-31),截至本公告披露日,公司暂未知悉上述事项的 进展及结论,公司将持续关注该事项后续进展情况,并根据相关规定及时履行信 息披露义务。 ...
年内A股35只医药股涨超50%,哪些因素在驱动?
Sou Hu Cai Jing· 2025-05-26 13:18
Core Viewpoint - The pharmaceutical sector in A-shares has shown significant performance in 2025, with many stocks experiencing substantial price increases, despite a recent pullback in the market [1][2]. Group 1: Market Performance - As of May 26, the A-share market saw the Shanghai Composite Index drop by 0.05% to 3346.84 points, with the Shenzhen Component Index down 0.41% and the ChiNext Index down 0.8% [1]. - The biopharmaceutical sector has had a strong year, with five stocks rising over 100% and 35 stocks increasing by more than 50% since the beginning of 2025 [1][2]. Group 2: Individual Stock Performance - Notable performers include Yong'an Pharmaceutical, which has seen a price increase of 171.34%, and other companies like Yipin Pharmaceutical and Sanofi National Health, with increases of 169.87% and 138.47%, respectively [3][4]. - The Wind data indicates that the Wande Innovation Drug Index and the Pharmaceutical and Biological Index have risen by 11.21% and 3.17%, respectively, outperforming major indices like the Shanghai Composite and CSI 300 [2]. Group 3: Factors Driving Stock Prices - Yong'an Pharmaceutical's stock price surge is attributed to rising international prices of taurine and strong sales performance of its functional beverage brand "Yijianeng" on e-commerce platforms [5]. - The recent authorization deal between Sanofi Pharmaceutical and Pfizer for a breakthrough PD-1/VEGF bispecific antibody has also driven stock prices, with potential total transaction value exceeding $6 billion [9]. - The acceleration of innovative drug development and the increasing focus on AI in healthcare are contributing factors to the rising stock prices of several pharmaceutical companies [10]. Group 4: Future Outlook - Analysts are optimistic about the investment opportunities in innovative drugs for the second half of 2025, citing the international competitiveness of China's innovative drug development [12]. - The pharmaceutical industry is expected to benefit from ongoing innovation, demographic trends, and favorable policy environments, with a focus on innovative drugs and consumer recovery [12].
永安药业涨停,3机构现身龙虎榜
Zheng Quan Shi Bao Wang· 2025-05-23 10:00
近半年该股累计上榜龙虎榜15次,上榜次日股价平均涨3.92%,上榜后5日平均涨8.63%。 资金流向方面,今日该股主力资金净流出1705.61万元,其中,特大单净流入3611.90万元,大单资金净 流出5317.51万元。近5日主力资金净流入3.26亿元。(数据宝) 永安药业今日涨停,全天换手率34.93%,成交额17.16亿元,振幅6.04%。龙虎榜数据显示,机构净买入 1877.17万元,营业部席位合计净卖出308.37万元。 深交所公开信息显示,当日该股因日涨幅偏离值达10.89%、日换手率达34.93%上榜,机构专用席位净 买入1877.17万元。 证券时报·数据宝统计显示,上榜的前五大买卖营业部合计成交3.69亿元,其中,买入成交额为1.92亿 元,卖出成交额为1.77亿元,合计净买入1568.80万元。 具体来看,今日上榜的营业部中,共有3家机构专用席位现身,即买二、买三、卖二、卖三、卖五,合 计买入金额7286.16万元,卖出金额5408.99万元,合计净买入1877.17万元。 永安药业5月23日交易公开信息 | 买/ | 会员营业部名称 | 买入金额(万 | 卖出金额(万 | | --- | ...
永安药业持续大涨背后:牛磺酸涨价叠加新品热卖
Xin Hua Cai Jing· 2025-05-23 09:09
Core Viewpoint - The surge in taurine prices and the popularity of functional beverages have significantly driven the stock price of Yong'an Pharmaceutical, which has seen a remarkable increase in recent weeks [2][9]. Group 1: Taurine Market Dynamics - Yong'an Pharmaceutical, the largest taurine producer globally, is projected to achieve approximately 635 million yuan in revenue from taurine raw materials in 2024, accounting for 75.69% of total revenue [7]. - Recent international taurine prices have exceeded $10 per kilogram, driven by trade war price expectations and U.S. regulations mandating taurine in infant formula and pet food [7][8]. - The global demand for taurine is estimated at 160,000 tons annually, while current production capacity is only 140,000 tons, resulting in a shortfall of about 20,000 tons [8]. Group 2: Functional Beverage Market Entry - Yong'an Pharmaceutical has successfully entered the functional beverage market, contributing to its recent stock price surge [9]. - The company's solid functional beverage brand, Yijianeng, has achieved significant sales, ranking first in popularity on various e-commerce platforms [10]. - The functional beverage market in China is projected to grow to 166.5 billion yuan by 2024, with a compound annual growth rate of 8.3% from 2019 to 2024, indicating substantial growth potential [10][11]. Group 3: Strategic Initiatives - The company has focused on the anti-fatigue market for its functional beverage offerings, with plans to launch its self-branded products by the end of 2024 [11]. - Yong'an Pharmaceutical is actively involved in the research, development, and production of taurine-based functional foods and health products [11].
5月23日午间涨停分析
news flash· 2025-05-23 03:40
5月23日午间涨停分析 智通财经5月23日电,今日午盘全市场共33股涨停,连板股总数6只,17股封板未遂,封板率为66%(不含ST股、退市股)。焦点股方面,机器人叠加核电概 念的中超控股15天9板,牛磺酸龙头永安药业8天6板,并购重组的滨海能源晋级5连板。 | 股票名称 | 板数 | 涨跌幅 | 涨停时间 | 上涨逻辑 | | --- | --- | --- | --- | --- | | 海森药业 | 2天2板 | 10.01% | 09:25 | 原料药 | | 001367 | | | | | | 众生药业 | 首板 | 10.02% | 09:25 | 创新药 | | 002317 | | | | 上市 | | 多瑞医药 | 首板 | 20.00% | 09:38 | 感冒药 | | 301075 | | | | | | 誉衡药业 | 首板 | 9.84% | 10:02 | 医药 | | 002437 | | | | | | 新天地 | | 18.13% | | 感冒药 | | 301277 | | | | +CRO | | 森萱医药 | | 15.07% | | 感冒药 | | 830946 | ...
晚间公告丨5月22日这些公告有看头





Di Yi Cai Jing· 2025-05-22 10:28
Group 1 - Yong'an Pharmaceutical announced that its stock price has seen a significant short-term increase, indicating a risk of market sentiment overheating, although there are no major changes in the company's fundamentals [3] - China Power Construction reported that from January to April 2025, the company signed new contracts worth 386.49 billion yuan, a decrease of 4.9% year-on-year [4] - Wanhua Chemical announced a scheduled maintenance for its production facilities, including a technical upgrade for its ethylene unit, which is expected to last approximately five months, while ensuring that other units continue to operate normally [5] Group 2 - Changhong High-Tech received a warning letter from the Ningbo Securities Regulatory Bureau for failing to timely disclose related party transactions exceeding expected amounts, with the company secretary held responsible [6] - Gaweida plans to invest 10 million yuan in Blue Core Computing, acquiring a 0.6729% stake in the company, which focuses on RISC-V architecture chip solutions [7] Group 3 - Zhongnan Media signed a government procurement contract worth 1.009 billion yuan, ensuring stable revenue from educational materials for the 2025 fiscal year [9] - Hongli Zhihui's controlling shareholder plans to increase their stake in the company by investing between 25 million and 50 million yuan [11] - Xingye Co.'s controlling shareholder intends to reduce their stake by up to 1% of the total share capital due to personal asset allocation needs [12] - Chengdu Xian Dao's employee stockholding platform plans to invest between 25 million and 50 million yuan to increase its stake in the company, with no set price range for the purchase [13]
永安药业: 关于股票交易异常波动暨风险提示公告
Zheng Quan Zhi Xing· 2025-05-22 10:27
证券代码:002365 证券简称:永安药业 公告编号:2025-35 潜江永安药业股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 重要风险提示: 证券代码:002365)股票交易价格于 2025 年 5 月 21 日、2025 年 5 月 22 日连续 两个交易日内日收盘价格涨幅偏离值累计超出 20%,根据深圳证券交易所的有关 规定,属于股票交易异常波动的情况。公司股价短期涨幅较大,敬请广大投资者 理性投资,注意投资风险。 公司股票交易价格于 2025 年 5 月 21 日、2025 年 5 月 22 日连续两个交易日 内日收盘价格涨幅偏离值累计超出 20%,根据深圳证券交易所的有关规定,属于 股票交易异常波动的情况。 二、公司关注、核实情况说明 针对公司股票交易异常波动,公司董事会对公司相关事项进行了核实,现 就有关情况说明如下: (一)经核查,公司前期披露的信息不存在需要更正、补充之处。 (二)经核查,除公司已披露的信息外,公司未发现近期公共媒体报道了可 能或者已经对公司股票交易价格产生较大影响的未公开重大信息。 (三)经核查,公司近期经营情 ...